Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4841475

Brc1cnc2[nH]c(-c3ccsc3)nc2c1.O=C(O)C(F)(F)F

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1B Q9Y463 1/20 0.38
CYP2A6 P11509 1/20 0.36
GSK3B P49841 2/20 0.36
CCNB2 O95067 1/20 0.36
CDK1 P06493 1/20 0.36
CCNB1 P14635 1/20 0.36
CDK5 Q00535 1/20 0.36
CDK5R1 Q15078 1/20 0.36
CCNB3 Q8WWL7 1/20 0.36
AXL P30530 1/20 0.35
CHEK2 O96017 2/20 0.34
DHODH Q02127 2/20 0.34
PDGFRB P09619 3/20 0.33
PDGFRA P16234 3/20 0.33
MMP2 P08253 1/20 0.33
MMP9 P14780 1/20 0.33
MMP8 P22894 1/20 0.33
MMP13 P45452 1/20 0.33
CDK8 P49336 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4844349 0.84 HPSE (0.36) MMP2MMP9MMP8MMP13
Trifluoroacetic Acid SCHEMBL4843644 0.80 PIN1 (0.49) DHODHHDAC6
Trifluoroacetic Acid SCHEMBL4834909 0.79 HDAC6 (0.47) CHEK2DHODHMMP2MMP9MMP8
Trifluoroacetic Acid SCHEMBL4842876 0.79 CHEK2 (0.45) CHEK2MMP2MMP9MMP8MMP13
Trifluoroacetic Acid SCHEMBL4842729 0.79 AURKA (0.52) GSK3BCCNB2CDK1CCNB1CCNB3
Trifluoroacetic Acid SCHEMBL4845932 0.79 DGAT1 (0.45) GSK3BCCNB2CDK1CCNB1CDK5
Trifluoroacetic Acid SCHEMBL4838856 0.78 TBK1 (0.43)
Trifluoroacetic Acid SCHEMBL5260040 0.78 ALDH1A1 (0.48) DYRK1BDHODHMMP2MMP9MMP8
Trifluoroacetic Acid SCHEMBL5259763 0.77 MMP2 (0.35) MMP2MMP9MMP8MMP13HDAC6
Trifluoroacetic Acid SCHEMBL5262965 0.77 PIN1 (0.51) HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7410966-B2 Use of and some novel imidazopyridines ASTRAZENECA AB (SE) 2008-08-12 US disclosed
EP-1539759-B1 NOVEL IMIDAZOPYRIDINES AND THEIR USE ASTRAZENECA AB (SE) 2007-08-15 EP disclosed
US-20050261333-A1 Use of and some novel imidazopyridines ASTRAZENECA A B (SE) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261333-A1 Use of and some novel imidazopyridines ITK, CSNK1A1, RPS6KA1 DYRK1B 944/4885CYP2A6 1643/4885GSK3B 993/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.